drugset / Trial / NCT02187497

Pharmacokinetics of BIBR 277 in Hypertensive Patients

NCT02187497

Phase 2 Completed 93 enrolled Boehringer Ingelheim
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The pharmacokinetic profile of BIBR 277 single dose given in capsule form to hypertensives was evaluated. The results of the present study are to be used in the Japanese population pharmacokinetics analysis

Timeline

Start
1998-06
Primary completion
1998-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Telmisartan Other / unclassified

Indications